α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney

It was indeed a Don Quixote-like pursuit of the mechanism of essential hypertension when we serendipitously discovered α2-adrenoceptors (α2-ARs) in skin-lightening experiments in the frog. Now α2-ARs lurk on the horizon involving hypertension causality, renal denervation for hypertension, injury fro...

Full description

Bibliographic Details
Main Authors: William A. Pettinger, Edwin K. Jackson
Format: Article
Language:English
Published: Hindawi-Wiley 2020-01-01
Series:Cardiovascular Therapeutics
Online Access:http://dx.doi.org/10.1155/2020/2478781
id doaj-004770b5de8e49a3b88d0491e0b99715
record_format Article
spelling doaj-004770b5de8e49a3b88d0491e0b997152020-11-25T02:59:24ZengHindawi-WileyCardiovascular Therapeutics1755-59141755-59222020-01-01202010.1155/2020/24787812478781α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the KidneyWilliam A. Pettinger0Edwin K. Jackson1Division of Clinical Pharmacology (Retired), University of Texas Southwestern Medical School (Retired), Bonita Springs, FL, USAUniversity of Pittsburgh School of Medicine, Department of Pharmacology and Chemical Biology, 100 Technology Drive, Room 514, Pittsburgh, PA 15219, USAIt was indeed a Don Quixote-like pursuit of the mechanism of essential hypertension when we serendipitously discovered α2-adrenoceptors (α2-ARs) in skin-lightening experiments in the frog. Now α2-ARs lurk on the horizon involving hypertension causality, renal denervation for hypertension, injury from falling in the elderly and prazosin’s mechanism of action in anxiety states such as posttraumatic stress disorder (PTSD). Our goal here is to focus on this horizon and bring into clear view the role of α2-AR-mediated mechanisms in these seemingly unrelated conditions. Our narrative begins with an explanation of how experiments in isolated perfused kidneys led to the discovery of a sodium-retaining process, a fundamental mechanism of hypertension, mediated by α2-ARs. In this model system and in the setting of furosemide-induced sodium excretion, α2-AR activation inhibited adenylate cyclase, suppressed cAMP formation, and caused sodium retention. Further investigations led to the realization that renal α2-AR expression in hypertensive animals is elevated, thus supporting a key role for kidney α2-ARs in the pathophysiology of essential hypertension. Subsequent studies clarified the molecular pathways by which α2-ARs activate prohypertensive biochemical systems. While investigating the role of α1-adrenoceptors (α1-ARs) versus α2-ARs in renal sympathetic neurotransmission, we noted an astonishing result: in the kidney α1-ARs suppress the postjunctional expression of α2-ARs. Here, we describe how this finding relates to a broader understanding of the role of α2-ARs in diverse disease states. Because of the capacity for qualitative and quantitative monitoring of α2-AR-induced regulatory mechanisms in the kidney, we looked to the kidney and found enlightenment.http://dx.doi.org/10.1155/2020/2478781
collection DOAJ
language English
format Article
sources DOAJ
author William A. Pettinger
Edwin K. Jackson
spellingShingle William A. Pettinger
Edwin K. Jackson
α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
Cardiovascular Therapeutics
author_facet William A. Pettinger
Edwin K. Jackson
author_sort William A. Pettinger
title α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
title_short α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
title_full α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
title_fullStr α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
title_full_unstemmed α 2-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
title_sort α 2-adrenoceptors: challenges and opportunities—enlightenment from the kidney
publisher Hindawi-Wiley
series Cardiovascular Therapeutics
issn 1755-5914
1755-5922
publishDate 2020-01-01
description It was indeed a Don Quixote-like pursuit of the mechanism of essential hypertension when we serendipitously discovered α2-adrenoceptors (α2-ARs) in skin-lightening experiments in the frog. Now α2-ARs lurk on the horizon involving hypertension causality, renal denervation for hypertension, injury from falling in the elderly and prazosin’s mechanism of action in anxiety states such as posttraumatic stress disorder (PTSD). Our goal here is to focus on this horizon and bring into clear view the role of α2-AR-mediated mechanisms in these seemingly unrelated conditions. Our narrative begins with an explanation of how experiments in isolated perfused kidneys led to the discovery of a sodium-retaining process, a fundamental mechanism of hypertension, mediated by α2-ARs. In this model system and in the setting of furosemide-induced sodium excretion, α2-AR activation inhibited adenylate cyclase, suppressed cAMP formation, and caused sodium retention. Further investigations led to the realization that renal α2-AR expression in hypertensive animals is elevated, thus supporting a key role for kidney α2-ARs in the pathophysiology of essential hypertension. Subsequent studies clarified the molecular pathways by which α2-ARs activate prohypertensive biochemical systems. While investigating the role of α1-adrenoceptors (α1-ARs) versus α2-ARs in renal sympathetic neurotransmission, we noted an astonishing result: in the kidney α1-ARs suppress the postjunctional expression of α2-ARs. Here, we describe how this finding relates to a broader understanding of the role of α2-ARs in diverse disease states. Because of the capacity for qualitative and quantitative monitoring of α2-AR-induced regulatory mechanisms in the kidney, we looked to the kidney and found enlightenment.
url http://dx.doi.org/10.1155/2020/2478781
work_keys_str_mv AT williamapettinger a2adrenoceptorschallengesandopportunitiesenlightenmentfromthekidney
AT edwinkjackson a2adrenoceptorschallengesandopportunitiesenlightenmentfromthekidney
_version_ 1715334969456328704